| Agree |
114 (42%) |
| Disagree |
84 (31%) |
| Can not decide |
74 (27%) |
|
| Access to MP-MRI limits my ability to use it in my practice. |
Total = 268 |
|
| Agree/Strongly agree |
192 (72%) |
| Disagree/Strongly disagree |
76 (28%) |
|
| The high cost of MP-MRI is prohibitive for its use. |
Total = 263 |
|
| Agree/Strongly agree |
156 (59%) |
| Disagree/Strongly disagree |
107 (41%) |
|
| MR-MPI guided biopsies are utilized in my practice. |
Total = 270 |
|
| Agree |
91 (34%) |
| Disagree |
179 (66%) |
|
| MP-MRI is helpful in patients with elevated PSA/abnormal prostate exam prior to biopsy. |
Total = 270 |
|
| Agree/Strongly agree |
102 (38%) |
| Disagree/Strongly disagree |
168 (62%) |
|
| MP-MRI is helpful in patients with negative biopsy and abnormal PSA/prostate exam. |
Total = 225 |
|
| Agree/Strongly agree |
88 (39%) |
| Disagree/Strongly disagree |
137 (61%) |
|
| MP-MRI is useful prior to definitive treatment with prostatectomy or radiation. |
Total = 225 |
|
| Agree/Strongly agree |
32 (14%) |
| Disagree/Strongly disagree |
193 (86%) |
|
| MP-MRI changes my treatment approach of intermediate/high risk prostate cancer. |
Total = 253 |
|
| Sometimes/often |
66 (26%) |
| Rarely/never |
187 (74%) |
|
| MP-MRI should be used in all patients for active surveillance. |
Total = 276 |
|
| Agree/Strongly agree |
69 (25%) |
| Disagree/Strongly disagree |
207 (75%) |
|
| How often do MP-MRI guided biopsies turn out to be positive? |
Total = 233 |
|
| Often/Very often |
65 (28%) |
| Sometimes |
77 (33%) |
| Rarely/Never |
91 (39%) |
|
| How closely do MP-MRI results correlate with final pathology after prostatectomy? |
Total = 233 |
|
| Strong correlation |
26 (11%) |
| Moderate correlation |
145 (62%) |
| Weak correlation |
46 (20%) |
| No correlation |
16 (7%) |
